Answers are grounded in this paper and cite their sources.
This study examined associations between a seven-session cognitive-behavioral therapy (CBT)-based group intervention and substance-use frequency, well-being, and psychological symptoms among university students. In a non-randomized, three-group quasi-experimental design, 90 students were allocated by session availability to CBT ( n = 34), inactive control ( n = 33), or active placebo ( n = 23) groups. CBT comprised seven weekly sessions of approximately 90 min. Assessments occurred at pretest, posttest, and 12-week follow-up. The Substance Use Frequency Scale assessed tobacco/nicotine use, heavy episodic alcohol consumption, and nonmedical prescription medication use; the Holistic Wellbeing Measure assessed hedonic and eudaimonic well-being; and the Brief Symptom Inventory-18 assessed somatization, depression, and anxiety. Six mixed-design ANOVAs showed significant Group × Time interactions for all outcomes (ηp 2 = 0.081–0.184). Baseline-adjusted comparisons using HC3-robust standard errors and Benjamini–Hochberg correction showed statistically significant differences favoring CBT in all 12 posttest and 10 of 12 follow-up contrasts. Follow-up comparisons with the active placebo group were not significant for eudaimonic well-being or somatization. CBT participation was associated with reduced substance-use frequency and psychological symptoms and increased well-being, although non-random allocation and low reliability of the substance-use composite limit interpretation. Clinical trial registration ClinicalTrials.gov , NCT07884422.
No takes yet. Share an insight, caveat, or question.
Hakan ACAR (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: